← Leaderboards
Thomas Kosten
Kadvax Technologies, Inc.
$152,988
Attributed
$305,976
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$305,976 · 1
By mechanism
R42$305,976 · 1
Top collaborators
- Yakov Kogan1 shared
Most similar at Kadvax Technologies, Inc.
Same institution · by research overlap
- Yakov Kogan$3,816,502
Others in their field
Other Emerging Leaders on “Adverse Effects”
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Kristin Aillon · Midwest Research Institute$23,644,534
- Abraham Aizer Brody · New York University School Of Medicine$21,887,280
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$21,828,548
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
Research focus
Adverse EffectsAdverse EventAgonistAlcoholsAlhydrogelAluminum SulfateAmericanAnimalsAntibodiesAntibody ResponseBaseBehavioralBloodBlood - Brain Barrier AnatomyBostonBrainCardiovascular SystemCaringCarrier ProteinsChemosensitizationCholeraClinical TrialsCocaineAdjuvant